RARB and cancer: On the other hand, RARβ antagonist (LE135) induced a potentiation of ATRA effect treatment on cancer stem cell self-renewal (Fig. 2i,j) indicating that RARβ might function as a buffer for retinoic acid response on cancer stem cell population.